Latest news
Showing 13/13 results
CN Bio licenses human gut microbiome modelling tool from MIT and Northeastern University
Mon 2 Aug 2021
CN-Bio Innovations
Lonza and CN Bio Announce Distribution Agreement
Tue 20 Jul 2021
CN-Bio Innovations
CN Bio’s PhysioMimix™ adopted by King’s College London to investigate chronic liver disease
Wed 7 Jul 2021
CN-Bio Innovations
CN Bio FDA collaboration expanded
Tue 11 May 2021
CN-Bio Innovations
Introducing the PhysioMimix™ OOC Multi-Organ Microphysiological System
Mon 22 Mar 2021
CN-Bio Innovations
CN Bio awarded Innovate UK grant to develop single and multi-organ models for COVID-19 research
Mon 8 Mar 2021
CN-Bio Innovations
How novel an in vitro Liver-on-a-Chip model of fatty liver disease is being used to help prevent a global healthcare crisis
Mon 1 Feb 2021
CN-Bio Innovations
CN Bio’s PhysioMimix™ technology receives FDA recognition
Mon 18 Jan 2021
CN-Bio Innovations
CN Bio and the University of Melbourne collaborate to advance therapies for respiratory complications in recovered COVID-19 patients
Mon 4 Jan 2021
CN-Bio Innovations
CN Bio to provide drug metabolism and safety toxicity testing services
Mon 9 Nov 2020
CN-Bio Innovations
CN Bio and Imperial College London Collaboration
Tue 8 Sep 2020
CN-Bio Innovations
CN Bio makes key senior appointments to support international commercial development
Mon 10 Aug 2020
CN-Bio Innovations
CN Bio and Cambridge University identify novel regulatory pathway driving NASH
Thu 18 Jun 2020
CN-Bio Innovations